KDPConsumer Defensive · Beverages - Non-AlcoholicThe 18 Wall Street analysts covering Keurig Dr Pepper, Inc. hold a median 12-month price target of $37 — +17.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 31 of 100 as at 13 Aug 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Keurig Dr Pepper, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (77): The share price has been relatively steady.
Accruals (25): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (6): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on KDP, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +17.7% from it.
Of the 20 most recent actions, 7 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 13 Aug 2026 | HSBC | Upgrade | Buy | $40 |
| 10 Aug 2026 | Barclays | Maintains | Overweight | $36 → $38 |
| 7 Aug 2026 | Evercore ISI Group | Maintains | In-Line | $30 → $32 |
| 7 Aug 2026 | UBS | Maintains | Buy | $38 → $39 |
| 23 July 2026 | JP Morgan | Maintains | Overweight | $33 → $38 |
| 23 July 2026 | JP Morgan | Maintains | Overweight | — |
| 16 July 2026 | UBS | Maintains | Buy | — |
| 16 July 2026 | UBS | Maintains | Buy | $34 → $38 |
| 14 July 2026 | Citigroup | Maintains | Buy | $32 → $37 |
| 14 July 2026 | Citigroup | Maintains | Buy | — |
| 25 June 2026 | Barclays | Upgrade | Overweight | $30 → $36 |
| 25 June 2026 | Barclays | Upgrade | Overweight | — |
| 12 June 2026 | Bernstein | Initiates | Outperform | — |
| 11 June 2026 | Bernstein | Initiates | Outperform | — |
| 27 Apr 2026 | Barclays | Maintains | Equal-Weight | — |
| 24 Apr 2026 | Evercore ISI Group | Maintains | In-Line | — |
| 24 Apr 2026 | JP Morgan | Maintains | Overweight | — |
| 24 Apr 2026 | UBS | Maintains | Buy | — |
| 22 Apr 2026 | BNP Paribas | Upgrade | Neutral | — |
| 16 Apr 2026 | JP Morgan | Maintains | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. KDP appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 26% of US stocks
Cheaper than 52% of US stocks
Cheaper than 52% of US stocks
Cheaper than 20% of US stocks
Higher than 91% of US stocks
Higher than 5% of US stocks
Higher than 66% of US stocks
Higher than 69% of US stocks
Higher than 64% of US stocks
Higher than 54% of US stocks
Higher than 68% of US stocks
Higher than 65% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Keurig Dr Pepper, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Keurig Dr Pepper sees the JDE Peet's integration, revenue synergies and $400 million in projected cost savings as factors that will boost coffee growth ahead of the planned 2027 separation, per Zacks Investment Research.
Why it matters — KDP watchers care because the anticipated synergies and cost savings from JDE Peet's could strengthen coffee growth leading up to the 2027 separation.
Keurig Dr Pepper announced that Aaron Alt has been appointed as a director to its Board of Directors, effective August 14, 2026. The announcement was made on August 12, 2026.
Why it matters — A new board appointment is relevant to KDP watchers as it signals a change in the company's governance and leadership oversight.
Zacks Investment Research published a comparison of Keurig Dr Pepper and Monster Beverage, examining which stock offers a better value opportunity for investors in the soft drinks sector.
Why it matters — KDP watchers would care because the article positions KDP relative to a major competitor on valuation grounds, which could influence investor perception.
Zacks Investment Research highlighted Keurig Dr Pepper, Inc (KDP) as a strong value stock using its Style Scores system. The article explains how the scoring tool helps investors identify top-rated stocks based on investing style.
Why it matters — KDP watchers would care because the Zacks Style Scores designation suggests the stock may be attractively valued compared to peers based on the research firm's methodology.
Keurig Dr Pepper was cited as a contributor to the Oakmark Concentrated Strategy portfolio's 9.21% net return in Q2 2026.
Why it matters — The mention as a positive contributor in a major fund's quarterly review signals that KDP's recent performance has been favorable relative to other holdings.
The 18 Wall Street analysts covering Keurig Dr Pepper, Inc. have a median 12-month price target of $37, with estimates ranging from $29 to $42. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 18 analysts covering Keurig Dr Pepper, Inc., 11 rate it a Buy, 7 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Keurig Dr Pepper, Inc. 31 out of 100 across roughly 4,600 US stocks as at 13 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 13 Aug 2026, Keurig Dr Pepper, Inc. ranks 31 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (77 of 100).
No one can know that. What the data says: the median 12-month target from 18 analysts implies +17.7% from the last close, and Ticker Nerd's factor model ranks Keurig Dr Pepper, Inc. 31 out of 100 as at 13 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Keurig Dr Pepper, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for KDP are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $29 to $42 over the next 12 months.
Keurig Dr Pepper, Inc. returned -6.3% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Keurig Dr Pepper Inc. is a leading North American beverage company that manufactures, markets, and distributes a broad portfolio of non-alcoholic drinks.
The most recent item we track (Zacks Investment Research, 13 Aug 2026): "Can JDE Peet's Become an Even Bigger Growth Driver for KDP?". Keurig Dr Pepper sees the JDE Peet's integration, revenue synergies and $400 million in projected cost savings as factors that will boost coffee growth ahead of the planned 2027 separation, per Zacks Investment Research.
Keurig Dr Pepper Inc. is a leading North American beverage company that manufactures, markets, and distributes a broad portfolio of non-alcoholic drinks. The company focuses on two primary areas: packaged beverages and coffee systems. Its refreshment beverages segment includes well-known soft drink, water, juice, and mixer brands such as Dr Pepper, Canada Dry, Snapple, Mott’s, Bai, CORE Hydration, and various energy and flavored drink lines. In coffee, Keurig Dr Pepper develops single-serve brewing systems and coffee pods under the Keurig and Green Mountain Coffee Roasters brands, along with numerous licensed partner brands. The company serves retailers, foodservice operators, and consumers across the United States, Canada, Mexico, and select international markets through extensive manufacturing and distribution networks. Founded in 2018 and headquartered in Burlington, Massachusetts, Keurig Dr Pepper plays a significant role in the consumer staples sector as a major provider of both hot and cold beverage solutions.
CEO Mr. Timothy P. Cofer · 50,000 employees · United States · https://www.keurigdrpepper.com